Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes

Diabetes

Volumn 48, Issue 10, 1999, Pages 2059-2065

  Ren, Jun ^a   Dominguez, Ligia J ^d   Sowers, James R ^b   Davidoff, Amy J ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FURA 2; GENISTEIN; GLIBENCLAMIDE; GLUCOSE; METFORMIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; HEART PROTECTION; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CALCIUM; ENZYME INHIBITORS; GENISTEIN; GLYBURIDE; HEART; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MYOCARDIUM; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032860998     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.10.2059     Document Type: Article

References (47)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
2. Sowers JR, Epstein M: Diabetes mellitus and associated hypertension, vascular disease and nephropathy: an update. Hypertension 26:869-879, 1995
3. Galderisi M, Anderson KM, Wilson PWF, Levy D: Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68:85-89, 1991
4. 2+] and pH in rat skinned cardiac myocytes. Am J Physiol 269:H1656-H1663, 1995
5. 2+ handling in ventricular myocytes isolated from diabetic rats. Am J Physiol 270:H1529-H1537, 1996
6. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 34:129-136, 1997
7. Davidoff AJ, Ren J: Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol 272: H159-H167, 1997
8. Ren J, Gintant GA, Miller RE, Davidoff AJ: High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol 273:H2876-H2883, 1997
9. Melin B, Cherqui G, Blivet MJ, Caron M, Lascols O. Capeau J, Picard J: Dual effect of metformin in cultured rat hepatocytes: potentiation of insulin action and prevention of insulin induced resistance. Metabolism 39:1089-1095, 1990
10. Matthaei S, Greten H: Evidence that metformin ameliorates cellular insulin-resistance by potentiating insulin-induced translocation of glucose transporters to the plasma membrane. Diabetes Metabolism 17:150-158, 1991
11. Chan JC, Tomlinson B, Critchley JA, Cockram CS, Walden RJ: Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care 16:1035-1038, 1993
12. Sundaresan P, Lykos D, Daher A, Diamond T, Morris R, Howes LG: Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM. Diabetes Care 20:692-697, 1997
13. Goo AKY, Carson DS, Bjelajac A: Metformin: a new treatment option for non-insulin-dependent diabetes mellitus. J Fam Pract 42:612-618, 1996
14. Verma S, Bhanot S, McNeill JH: Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. JPET 271:1334-1337, 1994
15. Verma S, McNeill JH: Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts. Am J Physiol 266:H714-H719, 1994
16. Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A: Cellular mechanism of metformin action involves glucose transporter translocation from an intra-cellular pool to the plasma membrane in L6 muscle cells. Endocrinol 131:1165-1173, 1992
17. Jacobs DB, Hayes GR, Truglia JA, Lockwood DH: Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes. Diabetologia 29:798-801, 1986
18. Fischer Y, Thomas J, Rosen P, Kammermeier H: Action of metformin on glucose transport and glucose transporter glut1 and glut4 in heart muscle cells from healthy and diabetic rats. Endocrinology 136:412-420, 1995
19. Dominguez LJ, Davidoff AJ, Srinivas PR, Standley PR, Walsh MF, Sowers JR: Effects of metformin on tyrosine kinase activity, glucose transport, and intra-cellular calcium in rat vascular smooth muscle. Endocrinol 137:113-121, 1996
20. Sasson S, Gorowits N, Joost HG, King GLCE, Kaiser N: Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells. Br J Pharmacol 117:1318-1324, 1996
21. Peuler JD, Miller JA, Bourghli M, Zamman HY, Solos EE, Sowers JR: Disparate effects of antidiabetic drugs on arterial contraction. Metabolism 46: 1199-1205, 1997
22. Sharma RV, Bhalla RC: Metaformin attenuates agonist-stimulated calcium transients in vascular smooth muscle cells. Clin Exp Hypertens 17:913-929, 1995
23. Ilarde A, Tuck M: Treatment of non-insulin-dependent diabetes mellitus and its complications: a state of the art review. Drugs Aging 4:470-491, 1994
24. Adams MD, Raman P, Judd RL: Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver. Biochem Pharmacol 55:1915-1920, 1998
25. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 83:27-33, 1996
26. Sargent CA, Wilde MW, Dzwonczyk S, Tuttle JG, Murray HN, Atwal K, Grover GJ: Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A, inhibition in ischemic rat hearts. Cardiovasc Res 30: 270-277, 1996
27. + currents in rat ventricular myocytes. Circ Res 74:620-628, 1994
28. Ren J, Davidoff AJ: Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272:H148-H158, 1997
29. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ: Troglitazone attenuates high glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes 45:1822-1825, 1996
30. Ruderman RB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J 6:2905-2914, 1992
31. Barbagallo M, Shan J, Pang PK, Resnick LM: Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest 95:763-767, 1995
32. 19F nuclear magnetic resonance studies of free calcium in heart cells. Biophysical Journal 65:2547-2558, 1993
33. 2+], of cardiac myocytes. Kidney Int 53:1237-1243, 1998
34. Barry WH, Bridge JHB: Intracellular calcium homeostasis in cardiac myocytes. Circulation 87:1806-1815, 1993
35. 2+ regulation in a cellular model of diabetic cardiomyopathy. FASEB J 10:203A, 1996
36. 2+ exchanger activity in the diabetic heart Cardiovasc Res 34:129-136, 1997
37. Marshall S, Garvey WT, Traxinger RR: New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J 5:3031-3036, 1991
38. Stith BJ, Goalstone ML, Espinoza R, Mossel C, Roberts D, Wiernsperger N: The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. Endocrinology 137:2990-2999, 1996
39. i in renal proximal tubular cells. Kidney Int 54:1206-1213, 1998
40. 2+ concentration oscillations in rat hepatocytes. Biochem J 304:561-567, 1994
41. Ren J, Davidoff AJ: High glucose-induced abnormal relaxation in cultured adult cardiac myocytes is prevented by inhibiting PKC. J Mol Cell Cardiol 29:A185, 1997
42. Giles TD, Ouyang J, Kerut EK, Given MB, Allen GE, McIlwain EF, Greenberg SS: Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am J Physiol 274:H295-H307, 1998
43. 2+ currents and not endothelial nitric oxide production. Diabetes 46: 659-664, 1997
44. Ghazzi MN, Perez JE, Antonucci TK, Driscoll JH, Huang SM, Faja BW, The Troglitazone Study Group, Whitcomb RW: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes 46:433-439, 1997
45. KAPT: an inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170, 1995
46. Sakura H, Ammala C, Smith PA, Gribble FM, Ashcroft FM: Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta cells, brain, heart, and skeletal muscle. FEBS Lett 377:338-344, 1995
47. Smits P, Thien T: Cardiovascular effects of sulphonylurea derivatives: implications for the treatment of NIDDM. Diabetologia 38:116-121, 1995